对肺癌筛查在PLCO试验中疗效的另一种解读。 - Suppr

Suppr

超能文献

A different interpretation of the efficacy of lung cancer screening in the PLCO trial.

作者信息

Sagawa Motoyasu, Nakayama Tomio, Sobue Tomotaka

机构信息

Department of Thoracic Surgery, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa, 920-0293, Japan.

Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.

出版信息

Eur J Epidemiol. 2016 Feb;31(2):211-2. doi: 10.1007/s10654-015-0070-1. Epub 2015 Jul 22.

DOI:10.1007/s10654-015-0070-1

PMID:26197850

Abstract

摘要

相似文献

A different interpretation of the efficacy of lung cancer screening in the PLCO trial.对肺癌筛查在PLCO试验中疗效的另一种解读。

Eur J Epidemiol. 2016 Feb;31(2):211-2. doi: 10.1007/s10654-015-0070-1. Epub 2015 Jul 22.

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.前列腺、肺、结肠和卵巢癌（PLCO）筛查试验中的死亡审查过程。

Control Clin Trials. 2000 Dec;21(6 Suppl):400S-406S. doi: 10.1016/s0197-2456(00)00095-7.

Update of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.前列腺、肺、结肠直肠癌和卵巢癌筛查试验的更新

Recent Results Cancer Res. 2014;202:53-7. doi: 10.1007/978-3-642-45195-9_6.

Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.一项大型多中心筛查试验的协调与管理：前列腺、肺、结肠和卵巢（PLCO）癌筛查试验。

Control Clin Trials. 2000 Dec;21(6 Suppl):310S-328S. doi: 10.1016/s0197-2456(00)00099-4.

Comprehensive Quality Management (CQM) in the PLCO Trial.前列腺、肺、结直肠癌和卵巢癌筛查试验中的全面质量管理（CQM）

Rev Recent Clin Trials. 2015;10(3):223-32. doi: 10.2174/1574887110666150730121113.

Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.黑人参与前列腺、肺、结肠直肠和卵巢（PLCO）癌筛查试验的情况。

Control Clin Trials. 2000 Dec;21(6 Suppl):379S-389S. doi: 10.1016/s0197-2456(00)00093-3.

Quality control of cancer screening examination procedures in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.前列腺、肺癌、结直肠癌和卵巢癌（PLCO）筛查试验中癌症筛查检查程序的质量控制

Control Clin Trials. 2000 Dec;21(6 Suppl):390S-399S. doi: 10.1016/s0197-2456(00)00094-5.

Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.前列腺、肺、结肠直肠癌和卵巢癌（PLCO）筛查试验中的招募策略：前六年

Control Clin Trials. 2000 Dec;21(6 Suppl):356S-378S. doi: 10.1016/s0197-2456(00)00102-1.

ACS releases updated guidelines on cancer screening.美国临床肿瘤学会发布癌症筛查更新指南。

Am Fam Physician. 2012 Sep 15;86(6):571, 576-7.

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.美国国立癌症研究所的前列腺、肺癌、结直肠癌和卵巢癌（PLCO）筛查试验：历史、组织与现状

Control Clin Trials. 2000 Dec;21(6 Suppl):251S-272S. doi: 10.1016/s0197-2456(00)00097-0.

本文引用的文献

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.胸部 X 光片筛查与肺癌死亡率：前列腺癌、肺癌、结直肠癌和卵巢癌（PLCO）随机试验。

JAMA. 2011 Nov 2;306(17):1865-73. doi: 10.1001/jama.2011.1591. Epub 2011 Oct 26.

Sojourn time and lead time projection in lung cancer screening.肺癌筛查中的逗留时间和领先时间预测。

Lung Cancer. 2011 Jun;72(3):322-6. doi: 10.1016/j.lungcan.2010.10.010. Epub 2010 Nov 13.

Mean sojourn time and effectiveness of mortality reduction for lung cancer screening with computed tomography.计算机断层扫描用于肺癌筛查的平均停留时间及降低死亡率的有效性。

Int J Cancer. 2008 Jun 1;122(11):2594-9. doi: 10.1002/ijc.23413.

The efficacy of lung cancer screening conducted in 1990s: four case-control studies in Japan.

Lung Cancer. 2003 Jul;41(1):29-36. doi: 10.1016/s0169-5002(03)00197-1.

Mammographic screening: no reliable supporting evidence?乳腺钼靶筛查：没有可靠的支持证据？

Lancet. 2002 Feb 2;359(9304):404-5. doi: 10.1016/S0140-6736(02)07592-X.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验